Mirum Pharmaceuticals (MIRM) EPS (Basic) (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,091.67% |
| Dec 31, 2025 | -300.00% |
| Sep 30, 2025 | 150.00% |
| Jun 30, 2025 | 60.00% |
| Mar 31, 2025 | 38.78% |
| Dec 31, 2024 | -63.33% |
| Sep 30, 2024 | 42.31% |
| Jun 30, 2024 | 3.70% |
| Mar 31, 2024 | 25.00% |
| Dec 31, 2023 | -26.32% |
| Sep 30, 2023 | 70.62% |
| Jun 30, 2023 | -142.50% |
| Mar 31, 2023 | 18.37% |
| Dec 31, 2022 | 3.92% |
| Sep 30, 2022 | -21.43% |
| Jun 30, 2022 | 28.21% |
| Mar 31, 2022 | -161.26% |
| Dec 31, 2021 | 223.23% |
| Sep 30, 2021 | -6.90% |
| Jun 30, 2021 | 13.69% |
| Mar 31, 2021 | -16.67% |
| Dec 31, 2020 | -67.44% |
| Sep 30, 2020 | 7.53% |
| Jun 30, 2020 | -8.14% |
| Mar 31, 2020 | -681.82% |
| Dec 31, 2019 | 86.90% |
| Sep 30, 2019 | 84.18% |
| Jun 30, 2019 | -124.05% |